Generex Biotechnology Corp (GNBT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Generex Biotechnology Corp (GNBT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12171
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using its proprietary RapidMist device. Generex through its subsidiary, Antigen Express, has expanded its focus to include immunomedicines incorporating proprietary vaccine formulations for the treatment of infectious, malignant, allergic, and autoimmune diseases. Generex is headquartered in Miramar, Florida, the US.

Generex Biotechnology Corp (GNBT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Generex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Generex Biotechnology Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Generex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Generex Biotechnology Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Generex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Generex Biotechnology Corp, Medical Equipment, Deal Details 10
Partnerships 10
Generex Biotech Enters into Licensing Agreement with CannScience Innovations 10
Generex Biotech to Enter into Co-Development Agreement with NHTherapeutics 11
Equity Offering 12
Generex Biotec Announces Private Placement Of Units For USD2 Million 12
Generex Biotechnology Raises USD0.8 Million in Private Placement of Series E 9% Convertible Preferred Stock and Warrants 14
Generex Biotechnology Announces Private Placement Of Units For US$1.2 Million 15
Generex Biotech Completes Private Placement Of Units For US$0.8 Million 16
Generex Biotechnology Completes Private Placement Of Units For US$0.75 Million 17
Generex Biotech Completes Private Placement Of Units For US$2 Million 18
Acquisition 20
Generex Biotech to Acquire Remaining 49% Stake in Hema Diagnostic Systems 20
Generex Biotech to Acquire 51% Stake in Regentys 21
Generex Biotech to Acquire 51% Stake in Olaregen Therapeutix 22
Generex Biotech Acquires 51% Interest in Hema Diagnostic Systems for USD15 Million 23
Generex Biotechnology to Acquire 51% Stake in MediTemp for USD5 Million 24
Generex Biotech to Acquire 51% Stake in Alfa Rhythm for USD5 Million 25
Generex Biotechnology Corp – Key Competitors 26
Generex Biotechnology Corp – Key Employees 27
Generex Biotechnology Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Corporate Communications 29
Nov 15, 2018: Generex announces appointment of executive management team 29
Oct 12, 2018: Generex announces Anthony S. Crisci, Esq., CPA as general manager, chief compliance officer and corporate counsel of its new, wholly-owned subsidiary, NuGenerex distribution solutions 31
Jun 25, 2018: Generex Names Terry Thompson As Chief Operating Officer 32
Jan 25, 2017: Yutaka Niihara, MD, MPH, CEO of Emmaus Appointed Executive Chairman of Generex Biotechnology 33
Product News 34
Jul 02, 2018: Generex Biotechnology Announces the Filing of a Patent for its New Diagnostic Point-of-Care Platform, the Express II 34
Other Significant Developments 35
Jan 04, 2018: Generex CEO Provides 2017 Year-End Summary to Stakeholders 35
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Generex Biotechnology Corp, Medical Equipment, Key Facts, 2017 2
Generex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Generex Biotechnology Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Generex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Generex Biotechnology Corp, Deals By Market, 2012 to YTD 2018 8
Generex Biotechnology Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Generex Biotech Enters into Licensing Agreement with CannScience Innovations 10
Generex Biotech to Enter into Co-Development Agreement with NHTherapeutics 11
Generex Biotec Announces Private Placement Of Units For USD2 Million 12
Generex Biotechnology Raises USD0.8 Million in Private Placement of Series E 9% Convertible Preferred Stock and Warrants 14
Generex Biotechnology Announces Private Placement Of Units For US$1.2 Million 15
Generex Biotech Completes Private Placement Of Units For US$0.8 Million 16
Generex Biotechnology Completes Private Placement Of Units For US$0.75 Million 17
Generex Biotech Completes Private Placement Of Units For US$2 Million 18
Generex Biotech to Acquire Remaining 49% Stake in Hema Diagnostic Systems 20
Generex Biotech to Acquire 51% Stake in Regentys 21
Generex Biotech to Acquire 51% Stake in Olaregen Therapeutix 22
Generex Biotech Acquires 51% Interest in Hema Diagnostic Systems for USD15 Million 23
Generex Biotechnology to Acquire 51% Stake in MediTemp for USD5 Million 24
Generex Biotech to Acquire 51% Stake in Alfa Rhythm for USD5 Million 25
Generex Biotechnology Corp, Key Competitors 26
Generex Biotechnology Corp, Key Employees 27
Generex Biotechnology Corp, Subsidiaries 28

List of Figures
Generex Biotechnology Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Generex Biotechnology Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Generex Biotechnology Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Generex Biotechnology Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Generex Biotechnology Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Generex Biotechnology Corp (GNBT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Precision System Science Co., Ltd. (7707):(医療機器分野)企業M&A及び提携動向
    Summary Precision System Science Co., Ltd. (PSS) is a medical device company. The company develops, manufactures and sells automated systems, instruments, software and others. Its products include automated nucleic acid isolation system, microarray sample preparation system, magnetic beads based mul …
  • Electronic Arts Inc.:企業のM&A・提携・投資分析
    Electronic Arts Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Electronic Arts Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Virgin Group Ltd.:企業のM&A・提携・投資分析
    Virgin Group Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Group Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Tennessee Valley Authority(エネルギー分野):企業M&A動向
    Summary Tennessee Valley Authority (TVA) is a corporate agency providing electricity for business customers and local power companies serving nine million people in parts of seven southeastern states. The agency generates power utilizing diverse sources of energy such as hydro, nuclear, fossil fuel …
  • BenefitStreet, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BenefitStreet, Inc. Mergers and …
  • Ingersoll-Rand plc:企業の戦略・SWOT・財務分析
    SummaryIngersoll-Rand plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Indorama Ventures PCL (IVL):企業の財務・戦略的SWOT分析
    Indorama Ventures PCL (IVL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Immuron Ltd (IMC):企業の財務・戦略的SWOT分析
    Summary Immuron Ltd (Immuron), formerly Anadis Ltd is a biopharmaceutical company that develops oral immunotherapy therapeutics using polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. It pro …
  • Condor Hospitality Trust Inc:戦略・SWOT・企業財務分析
    Condor Hospitality Trust Inc - Strategy, SWOT and Corporate Finance Report Summary Condor Hospitality Trust Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets …
  • Walter Diversified Services Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Walter Diversified Services Lim …
  • ITT Inc (ITT):企業の財務・戦略的SWOT分析
    ITT Inc (ITT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • iMedX, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' iMedX, Inc. Mergers and Acquisi …
  • Patrick Industries, Inc.:企業のM&A・提携・投資分析
    Patrick Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Patrick Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Noble Environmental Power LLC:企業のM&A・提携動向(発電分野)
    Summary Noble Environmental Power LLC (Noble) is a renewable energy company that designs and develops wind farms. The company operates four wind projects in North Country New York. Its wind projects include Noble Clinton windpark, Noble Ellenburg windpark, Noble Altona windpark and Noble Chateaugay …
  • Ayala Corporation (AC):企業のM&A・提携動向(エネルギー分野)
    Summary Ayala Corporation (Ayala) is a business conglomerate. The company, through its subsidiaries and affiliate manages diversified operations in various sectors such as real estate, financial services, telecommunications, water infrastructure, electronics manufacturing, automotive distributorship …
  • CNA Financial Corporation:企業の戦略・SWOT・財務分析
    SummaryCNA Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Medical Care Service Company Inc. (2494)(製薬・医療分野):企業M&A動向
    Summary Medical Care Service Company Inc. (MCSC) is a medical device company. The company offers medical equipment, from respiratory equipment and adjustable bed options, to enteral nutrition and home medical equipment, power mobility equipment and supplies. Its product categories include bilevel pa …
  • Suedzucker AG:企業の戦略・SWOT・財務分析
    SummarySuedzucker AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • UMB Financial Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' UMB Financial Corporation Merge …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆